89583-07-3

Basic information

• Product Name: 2-(4-Morpholine)ethyl bromide
• Synonyms: 2-(4-MORPHOLINE)ETHYL BROMIDE;2-MORPHOLINOETHYL BROMIDE;Morpholine, 4-(2-broMoethyl)-;4-(2-broMoethyl)Morpholine
• CAS NO: 89583-07-3
• Molecular Formula: C₆H₁₂BrNO
• Molecular Weight: 194.07
• Product Categories: pharmacetical
• Mol File: 89583-07-3.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 219.9 °C at 760 mmHg
• Flash Point: 86.8 °C
• Appearance: /
• Density: 1.393g/cm³
• Vapor Pressure: 0.116mmHg at 25°C
• Refractive Index: 1.495
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: 5.90±0.10(Predicted)
• CAS DataBase Reference: 2-(4-Morpholine)ethyl bromide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Morpholine)ethyl bromide(89583-07-3)
• EPA Substance Registry System: 2-(4-Morpholine)ethyl bromide(89583-07-3)

Safety Data

• Hazardous Substances Data: 89583-07-3(Hazardous Substances Data)

Usage

General Description

2-(4-Morpholine)ethyl bromide, also known as N-(2-Bromoethyl)morpholine, is a chemical compound that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is a clear, colorless liquid with a strong odor, and is highly reactive in nature. 2-(4-Morpholine)ethyl bromide is known to cause irritation to the skin, eyes, and respiratory tract upon contact or inhalation, and should be handled with appropriate safety measures. Due to its reactivity, it should be stored and handled with caution, and only by trained professionals following proper safety guidelines.

InChI:InChI=1/C6H12BrNO/c7-1-2-8-3-5-9-6-4-8/h1-6H2

Upstream product

• 102-71-6 triethanolamine 
• 10035-10-6 hydrogen bromide 
• 25114-70-9 triethanolammonium bromide 
• 110-91-8 morpholine 
• 558-13-4 carbon tetrabromide 
• 622-40-2 2-(morpholin-4-yl)ethanol 
• 110-54-3 hexane 
• 106-93-4 ethylene dibromide 

Downstream Products

• 2154-24-7 N-(2-hydrazinoethyl)morpholine 
• 1245927-52-9 C₂₉H₂₉ClN₆O₃S 
• 92623-83-1 pravadoline 
• 1428973-09-4 2-chloro-1-(1-(2-morpholinoethyl)-1H-indol-3-yl)-2-phenylethanone 
• 1426320-97-9 C₁₂H₁₅ClINO₂ 
• 1426321-00-7 C₁₈H₂₀ClN₃O₄ 
• 1426320-99-1 C₁₆H₁₇Cl₂N₃O₂ 
• 1426320-98-0 C₁₈H₂₇BClNO₄ 
• 1421702-17-1 C₂₁H₃₁N₅O₃ 

Relevant articles and documents

Lipid compound and composition thereof

The invention relates to a lipid compound and a composition thereof, a lipid nanoparticle containing the composition, a preparation method of the composition and application of the composition in drug delivery.

Cationic lipid molecule, and application thereof in nucleic acid delivery

The present invention discloses a cationic lipid molecule, and an application thereof in nucleic acid delivery. The structural formula of the cationic lipid molecule is represented by formula i. The invention further provides a cationic liposome, a lipid compound, a reagent, a kit, a preparation and a medicinal composition based on the cationic lipid molecule. The cationic lipid molecule has the advantages of simple synthesis process and good stability, and the cationic liposome has a high efficiency (characterized by high transfection efficiency) and a low toxicity, is stable and uniform, is easy to prepare, and can be used for transferring various cell lines. The cationic lipid molecule has excellent transitivity, and can efficiently deliver active substances (such as exemplary siRNA) omto cells (such as exemplary lung cancer cells), tissues and organs to achieve efficient regulation of the active substances. The problem that the toxicity and the transfer efficiency of cationic liposome existing in the prior art are low is solved.

KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

Certain chemical entities are provided herein. Also provided are pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and diso